Meisystem, Inc.

Meisystem, Inc., a foreign-owned subsidiary of MEI S.R.L. (an Italian optical equipment manufacturer based in Ponte San Pietro, Italy), operates as a prime contractor delivering optical and ophthalmic equipment, lens edging machines, preventive maintenance services, and eyeglass production consumables to federal healthcare agencies. The company does not hold SBA set-aside certifications and competes on a full-and-open basis; its federal footprint consists entirely of prime purchase orders and contracts with no subcontract activity.

Meisystem's capability portfolio centers on optical lab equipment sales and sustainment. Representative work includes a $1.77 million purchase order from the Department of Veterans Affairs Veterans Integrated Service Network 10 (awarded September 2021) for optical lens edging machines, conveyor belt, installation, calibration, and staff training to modernize VISN 10's optical lab in Indianapolis; a $675,352 sole-source purchase order from the Defense Health Agency (September 2024) for a MEI 4Racer Eyeglass Lens Edger system and supporting equipment for the Naval Medical Center San Diego Optometry Clinic; and a $373,200 purchase order from VISN 10 (May 2024) for new EASYFIT TREND MAX lens edging machines, conveyor belts, equipment installation, calibration, and employee training. The company also delivers preventive maintenance contracts, consumables (optical lab materials and eyeglass-making supplies), emergency repair services, and software licensing for optical production equipment.

Customer concentration is acute. The Department of Veterans Affairs Veterans Integrated Service Network 10 dominates the footprint, accounting for 8 of 17 awards and $2.7 million of the $4.3 million combined potential value. The Department of the Navy Bureau of Medicine and Surgery places 7 awards worth $889 thousand combined. The Defense Health Agency and the Department of Justice Bureau of Prisons together account for the remaining awards. Together, these four agencies represent 100% of Meisystem's federal footprint across the source data window.

Activity has grown modestly — two awards in 2022 to five in 2024 — though the recent trajectory shows a pullback with two awards in 2025 and one in 2026 year to date. Only one award (valued at $13 thousand) reaches ultimate completion within the next twenty-four months, exposing minimal near-term recompete risk. The combined obligated value across all awards is $4.3 million, representing 98% of combined potential value, indicating strong execution and cash collection across the portfolio. Meisystem operates as a product and service supplier rather than a systems integrator; its awards are transactional in nature (purchase orders and definitive contracts) rather than task-order-driven relationships, and place of performance spans multiple VA and Navy medical facilities and defense health installations.